Challenges in Protein Product Development
In this volume, the authors discuss the many significant challenges currently faced in biotechnology dosage form development, providing guidance, shared experience and thoughtful reflection on how best to address these potential concerns. As the field of therapeutic recombinant therapeutic proteins...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
| Έκδοση: | 1st ed. 2018. |
| Σειρά: | AAPS Advances in the Pharmaceutical Sciences Series,
38 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part 1. Formulation Development of Biologics
- Introduction into Formulation Development of Biologics
- Part 2. Challenges with Excipients
- Polysorbate Degradation and Quality
- Sucrose and Trehalose in Therapeutic Protein Formulations
- Part 3. High Concentration Proteins
- Introduction to High-Concentration Proteins
- Solubility, Opalescence & Particulate Matter
- Analytical Characterization and Predictive Tools for Highly Concentrated Protein Formulations
- Practical Considerations for High Concentration Protein Formulations
- Part 4. Container-Closure Systems
- Parenteral Container Closure Systems
- Development of Prefilled Syringe Combination Products for Biologics
- Special Topics in Analytics of Pre-filled Syringes
- C Mini-Pumps
- Container Closure Integrity Testing of Primary Containers for Parenteral Products
- Chemical Durability of Glass - Delamination
- Part 5. Processing Considerations
- Bulk Protein Solution: Freeze Thaw Process, Storage and Shipping Considerations
- Leachables and Extractables: From Regulatory Expectations to Laboratory Assessment
- Biotherapeutic Drug Product Manufacturing and Process Development
- Line Sterilization Considerations and VHP
- Lyophilization: Process Design, Robustness and Risk Management
- Fogging
- Scientific Approaches for the Application of QbD Principles in Lyophilization Process Development
- Manufacturing of Highly Potent Drug Product in a Clinical Multi-Product Aseptic Facility and Transfer of Principles to Antibiotic Drug Product
- Part 6. Novel Constructs
- Introduction into Novel Constructs
- Novel Constructs - Half-Life Extensions
- Fc Fusion Proteins
- Part 7. Lifecycle Management
- Lifecycle Management of Biotherapeutic Dosage Forms
- Switching from an IV to an SC Formulation - Considerations for Formulation Development and Formulation Bridging.
